FIELD: medicine. SUBSTANCE: every of individual components of a pattern is a mini-tablet of less 5 mm size. All mini-tablets have practically the same size. Mini-tablet consists of a nucleus covered with two membranes. Nucleus contains an active ingredient such as calcitonin or ferritin. One of the membranes is designed from polymer soluble at pH above 5.0. The second membrane is made of practically insoluble polymer, which is permeable for gastrointestinal liquids. Multi-component dosed pattern at pH under the value of 4.5 reveals not higher than 10% calcitonin or ferritin. The rest part of an active ingredient is revealed at pH equal or above 5 during 0.5-8 hours. EFFECT: higher efficiency to provide controlled isolation of active intestinal ingredient. 8 cl
Title | Year | Author | Number |
---|---|---|---|
SOLID MEDICINAL FORM FOR ORAL ADMINISTRATION OF PHARMACEUTICALLY ACTIVE SUBSTANCES SHOWING UNFAVORABLE ORGANOLEPTIC PROPERTIES | 1991 |
|
RU2085190C1 |
MEDICINAL CONTROLLED-RELEASING FORMS OF AZITHROMYCIN | 1995 |
|
RU2130311C1 |
FORMULATIONS FOR ORAL DELIVERY OF ADSORBENTS IN INTESTINE | 2016 |
|
RU2681315C2 |
SOLID DOSAGE FORM FOR ORAL ADMINISTRATION WITH CONTROLLED RELEASE OF EFFECTIVE AGENT AND PROCESS FOR PREPARATION THE SAME | 1991 |
|
RU2012330C1 |
GASTRORESISTANT PHARMACEUTICAL COMPOSITIONS CONTAINING RIFAXIMIN | 2006 |
|
RU2403015C2 |
METHOD OF PROGRAMMED FLOATING DELIVERY | 2007 |
|
RU2420268C2 |
SOLID PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION | 1992 |
|
RU2120798C1 |
PHARMACEUTICAL COMPOSITIONS OF METABOTROPIC GLUTAMATE RECEPTOR 5 (MGLU5) ANTAGONISTS | 2011 |
|
RU2602955C2 |
DRUG-RELEASING SYSTEM SHOWING SPECIFICITY TO LARGE INTESTINE | 1995 |
|
RU2155605C2 |
COMPOSITION FOR ENTERIC COATING OF LECTIN-CONTAINING NATURAL PRODUCT | 2004 |
|
RU2315595C2 |
Authors
Dates
1998-05-27—Published
1991-04-09—Filed